
Watch the full episode below:
Listen to the full episode on Spotify:
Glenniss Richards, Senior Director of Media Activation at Bayer U.S. Pharma, on building in-house from scratch, redefining compliant creativity, and why personalization and AI are shaping the future of patient and HCP engagement.
In this episode of solli Sessions, Glenniss Richards shares the inside story of one of the most ambitious media transformations in pharma — Bayer’s in-housing journey, which she led from the ground up. What began as “build the team, build the plane while flying it” has become a case study in agility, transparency, and executive-level alignment.
Glenniss unpacks how Bayer moved from external dependency to full internal activation across channels, why trust and change-management were the real unlocks, and how her team’s work now connects directly to real patients, caregivers, and outcomes. She reflects on the shift from pharma being “10 years behind” to a digitally-mature, data-driven landscape where first-party relationships, AI-powered curation, and social platform activation are advancing faster than ever.
What to expect from this episode:
Leading In-Housing at Scale
How Glenniss architected Bayer’s end-to-end media transformation — bringing every channel in-house in just 18 months and proving that disruption, when supported top-down, becomes momentum, not chaos.
Change-Management + Trust...
Create your FREE account to continue reading and explore more expert insights on Pharma Media.
✅ Free. Fast. No commitment.